Literature DB >> 8384267

Oligodendrocyte differentiation and progenitor cell proliferation are independently regulated by cyclic AMP.

D W Raible1, F A McMorris.   

Abstract

Oligodendrocytes, the glial cells specialized to synthesize myelin in the central nervous system, differentiate in primary rat brain cell cultures on a schedule similar to that observed in vivo. The schedule of oligodendrocyte differentiation and the rate of oligodendroglial progenitor cell proliferation in vitro are both modulated by 3',5'-cyclic AMP (cAMP). A 24-hour exposure to 1 mM N6,2'O-dibutyryladenosine 3',5'-cyclic monophosphate (dbcAMP) induced a wave of oligodendrocyte differentiation but inhibited proliferation of oligodendroglial progenitors, and reduced by 30-fold the proliferation of progenitors in response to platelet-derived growth factor (PDGF). When cells were grown in the presence of maximally stimulating concentrations of PDGF, the inhibitory effect of cAMP on progenitor cell proliferation was abolished while the stimulatory effect of cAMP on oligodendrocyte differentiation remained, demonstrating that these two cAMP-regulated events are independent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384267     DOI: 10.1002/jnr.490340305

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  14 in total

1.  Post-transcriptional regulation of PDGFα-receptor in O-2A progenitor cells.

Authors:  Haiying Li; Chiayeng Wang
Journal:  Int J Clin Exp Med       Date:  2011-10-12

2.  Growth in North American white children with neurofibromatosis 1 (NF1).

Authors:  J Szudek; P Birch; J M Friedman
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

3.  Effects of cyclic AMP on expression of myelin genes in the N20.1 oligodendroglial cell line.

Authors:  D M Studzinski; R Ramaswamy; J A Benjamins
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent.

Authors:  Shweta S Puntambekar; Deirdre S Davis; Leo Hawel; Janelle Crane; Craig V Byus; Monica J Carson
Journal:  Brain Behav Immun       Date:  2011-01-13       Impact factor: 7.217

5.  Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells.

Authors:  C A Ghiani; X Yuan; A M Eisen; P L Knutson; R A DePinho; C J McBain; V Gallo
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

6.  PPAR-γ activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage.

Authors:  Sunil Krishna; Bokun Cheng; Deep R Sharma; Sunita Yadav; Erin S Stempinski; Sahil Mamtani; Elisa Shah; Anjali Deo; Trishna Acherjee; Teena Thomas; Xusheng Zhang; Jinghang Zhang; Dumitru A Iacobas; Praveen Ballabh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

7.  Differing in vitro survival dependency of mouse and rat NG2+ oligodendroglial progenitor cells.

Authors:  Makoto Horiuchi; Tullia Lindsten; David Pleasure; Takayuki Itoh
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

8.  Activation of cell cycle regulatory proteins in the apoptosis of terminally differentiated oligodendrocytes.

Authors:  M Strazza; A Luddi; A Brogi; M Carbone; M Riccio; S Santi; M Melli; E Costantino-Ceccarini
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

9.  Transcriptional regulation of the human UDP-galactose:ceramide galactosyltransferase (hCGT) gene expression: functional role of GC-box and CRE.

Authors:  Tewin Tencomnao; Dmitri Kapitonov; Erhard Bieberich; Robert K Yu
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

10.  Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination.

Authors:  C Takahashi; R Muramatsu; H Fujimura; H Mochizuki; T Yamashita
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.